Does Larger Dose of Steroid Improve the Outcome of Intra-Articular Hip Injection?
DOI:
https://doi.org/10.12970/2310-9874.2014.02.01.2Keywords:
Hip injection, corticosteroids, osteoarthritis of hip, treatment hip painAbstract
Introduction: Intra-articular hip injection has been used to treat arthritic hip pain for decades. However there is no standardised recommended does and there has been variability amongst surgeons.
Objective: We aimed to determine if larger dose of steroid injected improved the duration of pain relief.
Patients and Method: We retrospectively reviewed, two matched groups of patients treated with variable doses of triamcinolone hip injection; Group A with 40mg and Group B with 80mg. The duration of pain relief after hip injection was recorded in days, weeks or months for patients in each group.
Results: In Group A, 7 patients had no pain relief at all from the hip injection, 13 for only days (less than a week), 15 patients for weeks (up to 4 weeks) and 25 patients had complete pain relief till the time of follow-up at 3 months. Similarly in group B, 6 patients had no pain relief at all from hip injection, 14 for days, 18 patients for weeks and 22 patients for 3 months. The duration of pain relief from the hip injection for both Group A (6.2weeks) and B (6.1weeks) was similar with an overall average pain relief of 6.15weeks.
Conclusion: 40mg of steroid had same duration of pain relief compared to 80mg of steroid for treating primary hip osteoarthritis.
References
Gray RG, Tenenbaum J, Gottlieb NL. Local corticosteroid injection treatment in rheumatic disorders. Semin Arthritis Rheum 1981; 10: 231-54. http://dx.doi.org/10.1016/0049-0172(81)90001-9
Stefanich RJ. Intraarticular corticosteroids in treatment of osteoarthritis. Orthop Rev 1986; 15: 65-71.
Hollander JL. Intra-articular hydrocortisone in arthritis and allied conditions; a summary of two years' clinical experience. J Bone Joint Surg Am 1953; 35-A: 983-90.
British Medical Association and the Royal Society of Great Britain. British National Formulary 2006; 51: 516.
Raynauld JP, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Erratum appears in Arthritis Rheum 2003; 48: 3300. Arthritis Rheuma 2003; 48: 370-7. http://dx.doi.org/10.1002/art.10777
Schumacher HR, Jr. Synovial inflammation, crystals, and osteoarthritis. J Rheumatol Suppl 1995; 43: 101-3.
Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial.see comment. J Bone Joint Surg Am 2003; 85-A: 1197-203.
Hills BA, Ethell MT, Hodgson DR. Release of lubricating synovial surfactant by intra-articular steroid. Br J Rheumatol 1998; 37: 649-52. http://dx.doi.org/10.1093/rheumatology/37.6.649
Chandler GN, Jones DT, Wright V, Hartfall SJ. Charcot's arthropathy following intra-articular hydrocortisone. Br Med J 1959; 1: 952-3. http://dx.doi.org/10.1136/bmj.1.5127.952
Kaspar S, de V de Beer J. Infection in hip arthroplasty after previous injection of steroid. J Bone Joint Surg Br 2005; 87: 454-7. http://dx.doi.org/10.1302/0301-620X.87B4.15546
Zhang W, Doherty M, Arden N, et al. EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). EULAR evidence based recommendations for the management of hip osteoarthritis: report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2005; 64: 669-81. http://dx.doi.org/10.1136/ard.2004.028886
